Lidan He

Prof. Dr. Lidan He


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 October 2023 in Placenta
Verified
Journal Article
Closed access
LHLidan He
Lidan He
XWXiuyan Wu
Xiuyan Wu
FZFeng Zhan
Feng Zhan
XLXuemei Li
Xuemei Li
JWJianbo Wu
Jianbo Wu

18 December 2023 in IEEE Journal of Biomedical and Health Informatics
Verified
Journal Article
Closed access
FZFeng Zhan
Feng Zhan
WWWenwu Wang
Wenwu Wang
QCQian Chen
Qian Chen
YGYina Guo
Yina Guo
LHLidan He
Lidan He
LWLILI WANG
LILI WANG
Biomedical image segmentation of organs, tissues and lesions has gained increasing attention in clinical treatment planning and navigation, which involves the exploration of two-dimensional (2D) and three-dimensional (3D) contexts in the biomedical image. Compared to 2D methods, 3D methods pay more attention to inter-slice correlations, which offer additional spatial information for image segmentation. An organ or tumor has a 3D structure that can be observed from three directions. Previous studies focus only on the vertical axis, limiting the understanding of the relationship between a tumor and its surrounding tissues. Important information can also be obtained from sagittal and coronal axes. Therefore, spatial information of organs and tumors can be obtained from three directions, i.e. the sagittal, coronal and vertical axes, to understand better the invasion depth of tumor and its relationship with the surrounding tissues. Moreover, the edges of organs and tumors in biomedical image may be blurred. To address these problems, we propose a three-direction fusion volumetric segmentation (TFVS) model for segmenting 3D biomedical images from three perspectives in sagittal, coronal and transverse planes, respectively. We use the dataset of the liver task provided by the Medical Segmentation Decathlon challenge to train our model. The TFVS method demonstrates a competitive performance on the 3D-IRCADB dataset. In addition, the t-test and Wilcoxon signed-rank test are also performed to show the statistical significance of the improvement by the proposed method as compared with the baseline methods. The proposed method is expected to be beneficial in guiding and facilitating clinical diagnosis and treatment.

29 April 2024 in Journal of Ovarian Research
Verified
Journal Article
Open access
PDF file
FZFeng Zhan
Feng Zhan
YGYina Guo
Yina Guo
LHLidan He
Lidan He
Purpose: This study aims to explore the contribution of differentially expressed programmed cell death genes (DEPCDGs) to the heterogeneity of serous ovarian cancer (SOC) through single-cell RNA sequencing (scRNA-seq) and assess their potential as predictors for clinical prognosis. Methods: SOC scRNA-seq data were extracted from the Gene Expression Omnibus database, and the principal component analysis was used for cell clustering. Bulk RNA-seq data were employed to analyze SOC-associated immune cell subsets key genes. CIBERSORT and single-sample gene set enrichment analysis (ssGSEA) were utilized to calculate immune cell scores. Prognostic models and nomograms were developed through univariate and multivariate Cox analyses. Results: Our analysis revealed that 48 DEPCDGs are significantly correlated with apoptotic signaling and oxidative stress pathways and identified seven key DEPCDGs (CASP3, GADD45B, GNA15, GZMB, IL1B, ISG20, and RHOB) through survival analysis. Furthermore, eight distinct cell subtypes were characterized using scRNA-seq. It was found that G protein subunit alpha 15 (GNA15) exhibited low expression across these subtypes and a strong association with immune cells. Based on the DEGs identified by the GNA15 high- and low-expression groups, a prognostic model comprising eight genes with significant prognostic value was constructed, effectively predicting patient overall survival. Additionally, a nomogram incorporating the RS signature, age, grade, and stage was developed and validated using two large SOC datasets. Conclusion: GNA15 emerged as an independent and excellent prognostic marker for SOC patients. This study provides valuable insights into the prognostic potential of DEPCDGs in SOC, presenting new avenues for personalized treatment strategies.

21 February 2025 in BMC Pregnancy and Childbirth
Verified
Journal Article
Open access
PDF file
LHLidan He
Lidan He
FZFeng Zhan
Feng Zhan
XLXuemei Li
Xuemei Li
HYHuijuan Yang
Huijuan Yang
JWJianbo Wu
Jianbo Wu
Preeclampsia (PE) is a severe pregnancy complication with limited early diagnostic and therapeutic options. Ferroptosis, an iron-dependent cell death pathway, has emerged as a potential mechanism in PE pathogenesis. This study investigated ferroptosis-related genes (FRGs) in PE to identify diagnostic biomarkers and therapeutic targets. Differentially expressed genes were identified from GEO databases and intersected with FRGs. Hub genes were selected using RandomForest and LASSO algorithms. Their diagnostic potential was evaluated through ROC analysis. Regulatory networks were constructed using transcription factors, microRNAs and potential drug targets. Hub gene expression was validated through immunohistochemistry, Western blot, and RT-qPCR in placental tissues and hypoxic trophoblasts. We identified 25 ferroptosis-related differentially expressed genes enriched in ferroptosis and HIF-1 pathways. Four hub genes (NDRG1, P4HA1, LDHA, and IDO1) showed high diagnostic efficiency (AUC=0.9182). Immune cell analysis revealed altered levels of plasma cells, CD8+ T cells, Tregs, monocytes, and M2 macrophages in PE, correlating significantly with hub gene expression. We identified 84 mRNA-miRNA and 119 mRNA-TF interactions. Among 19 potential drugs, Tetrahydro-NAD showed promising targeting potential. Experimental validation confirmed elevated expression of NDRG1, P4HA1, and LDHA, and decreased IDO1 in PE tissues and hypoxic conditions. This study identified four FRGs as potential PE biomarkers and therapeutic targets, providing new insights into PE pathogenesis through integrated bioinformatics and experimental validation. These findings may facilitate early PE diagnosis and treatment development.

7 October 2023 in Acta Diabetologica
Verified
Journal Article
Closed access
PDF file
XZXia Zhang
Xia Zhang
XWXiuyan Wu
Xiuyan Wu
LCLihong Chen
Lihong Chen
LHLidan He
Lidan He

25 February 2025 in Journal of Reproductive Immunology
Verified
Journal Article
Closed access
LHLidan He
Lidan He
SZShan Zheng
Shan Zheng
FZFeng Zhan
Feng Zhan
NLNa Lin
Na Lin